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Introduction
Cardiovascular disease (CVD) is the leading cause of morbid-
ity and mortality among industrialized nations. CVD is respon-
sible for 31% of global mortality, accounting for approximate-
ly 17.5 million deaths from CVD in 2012 alone. Of these deaths, 
an estimated 7.4 million were attributable to coronary artery 
pISSN 1975-4612/ eISSN 2005-9655 
Copyright © 2015 Korean Society of Echocardiography 
www.kse-jcu.orghttp://dx.doi.org/10.4250/jcu.2015.23.4.195
REVIEW J Cardiovasc Ultrasound  2015;23(4):195-203
disease (CAD) and approximately 6.7 million due to stroke.1) 
Notably, prior epidemiologic evidence indicates that these mor-
bidity and mortality rates attributable to CVD tend to vary de-
pending on race, ethnicity, or geographic regions, even within 
a particular country.2-6) In an effort to prevent adverse cardiovas-
cular events, accurate assessment of absolute CVD risk is para-
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There is some disparity in the morbidity and mortality rates of cardiovascular disease (CVD) according to race, ethnicity, and geo-
graphic regions. Although prediction algorithms that evaluate risk of cardiovascular events have been established using tradition-
al risk factors, they have also demonstrated a number of differences along with race and ethnicity. Of various risk assessment mo-
dalities, coronary artery calcium (CAC) score is a sensitive marker of calcific atherosclerosis and correlates well with atherosclerotic 
plaque burden. Although CAC score is now utilized as a useful tool for early detection of coronary artery disease, prior studies 
have suggested some variability in the presence and severity of coronary calcification according to race, ethnicity, and/or geo-
graphic regions. Among Asian populations, it would appear necessary to reappraise the utility of CAC score and whether it re-
mains superior over and above established clinical risk prediction algorithms. To this end, the Korea initiatives on coronary artery 
calcification (KOICA) registry has been designed to identify the effectiveness of CAC score for primary prevention of CVD in as-
ymptomatic Korean adults. This review discusses the important role of CAC score for prognostication, while also describing the 
design and rationale of the KOICA registry.
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mount. Though to date, several studies have documented some 
discrepancies based on ethnicity or geographic region when uti-
lizing risk prediction algorithms for the assessment of adverse 
cardiovascular risk.7-13)
Foremost, coronary artery calcium (CAC) score is considered 
a robust method for early detection of CAD, and the use of CAC 
score is primarily recommended for risk stratification in national 
guidelines.14) Yet, it has emerged that there exists some ethnic 
disparity in the features of coronary calcification.15-18) Further 
still, most studies thus far related to CAC score are based on 
populations derived from Western societies. Given that CAC 
score has been reported to provide additional prognostic value 
beyond conventional risk prediction tools, it seems prudent 
that the predictive value of CAC score, particularly among 
Asian populations, is necessary. In relation, the Korea initia-
tives on coronary artery calcification (KOICA) registry is a 
novel study designed to assess the effectiveness of CAC score 
for primary prevention of CVD in a large cohort of asymptom-
atic Korean adults. In the following review, we describe the 
design and rationale of the KOICA registry, and how it might 
lend further insight towards the clinical utility of CAC score for 
prognostication in non-Western populations.
Ethnic and Racial Disparity 
in the Presence of CVD
CVD reflects a cluster of disorders in the heart and blood 
vessels including CAD and stroke. Although CVD manifests 
clinically as various diseases, CAD and stroke account for ap-
proximately 75% of all CVD-related deaths.19) Globally, CVD 
accounts for the highest number of deaths related to any cause, 
thus contributing extensively to the economic burden associ-
ated with health costs. Notably, over three quarters of CVD 
deaths typically occur in low-to-middle income countries, with 
the rate beginning to increase further in most Asian countries.1)
In light of the epidemiologic disparities in CVD,3-6) previous 
studies have demonstrated differing CVD mortality rates based 
on race, ethnicity, and geographic region.4)20-23) While the results 
have been largely heterogeneous in most studies, CAD mor-
tality in Black individuals is somewhat higher compared with 
other races. Moreover, Asian populations tend to present with 
lower mortality as compared with other racial groups (Fig. 1). 
In a large international study of individuals representing seven 
pre-defined ethnic/racial groups, Meadows et al.3) demonstrat-
ed the important ethnic-specific differences in cardiovascular 
risk factors as well as variations in cardiovascular mortality. 
Specifically, among all Asian groups that included East Asians, 
South Asians, and other Asians, the cardiovascular death rates 
were significantly lower compared with other groups (overall, 
2.1% vs. 4.5%, p < 0.001). Data from World Health Organi-
zation describing age-adjusted mortality rates of CAD and 
stroke have also demonstrated different results between West-
ern countries and some selected Asian countries in 2002.4) 
Considering the rapid rise in Asian populations, now com-
prising 60% of the world’s current population,24) CVD preven-
tion in this ethnic subgroup is of significant health concern. In 
South Korea, stroke mortality rate has continuously declined 
since the 2000s, whereas CAD mortality rate has paradoxically 
increased since the 1980s.25) In the World Health Organization 
multinational monitoring of trends and determinants in cardio-
vascular disease project, CVD incidence among numerous coun-
tries was examined, using standardized diagnostic criteria.5)6) 
The age-adjusted incidence rates of acute myocardial infarction 
and stroke were compared among the different countries. No-
tably, Japan and China did not appear to have a higher inci-
dence of stroke when compared with Western nations. Howev-
er, the latter East Asian countries had a much lower incidence 
of acute myocardial infarction compared with those Western 
populations. Subsequently, East Asian countries may appear to 
have a lower incidence of CAD-related events as compared with 
Western countries.
The heterogeneity in morbidity and mortality linked to CVD 
may be due to some ethnic dissimilarities in the prevalence of 
coronary artery atherosclerosis and related risk factors,26) along-
side possible variability in the utilization of preventive thera-
pies or availability of health care services.27) Despite this, some 
variation in CVD may result from diverse mechanisms of plaque 
formation, erosion, rupture, or occlusive thrombosis, all of which 
may lead to acute coronary events.28) Thus, any racial or ethnic 
differences in CVD can potentially be studied for identifica-
tion of persons with subclinical atherosclerosis and correlated 
risk.29) Recently a remarkable decline in the risk of CAD mor-
tality in developed Western countries may likely reflect a re-
duction in the prevalence of cardiovascular risk factors, along 
with improved medical management.30) On the other hand, as 
a result of industrialization and substantial economic develop-
ment throughout Asia, the prevalence of obesity and type 2 di-
abetes mellitus (DM) has markedly risen in Asian nations, pri-
marily due to altered diet and adopting a sedentary lifestyle.31) 
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Fig. 1. Age-adjusted death rates of CAD and CVD according to race/
ethnicity. CAD: coronary artery disease, CVD: cardiovascular disease.
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countries as compared with Western countries, the increasing 
metabolic risk factors, such as glucose intolerance, hypercho-
lesterolemia and insufficient control of hypertension, may well 
have contributed towards the trend in CAD incidence in Asian 
populations.
Racial and Ethnic Variation in Risk 
Prediction Algorithms
A significant number of patients with nonfatal myocardial 
infarction or sudden cardiac death often do not demonstrate a 
history of any prior symptoms or cardiovascular diagnosis.32) 
Hence, treatments focused on patients who already experi-
enced symptoms may have some inherent limitations when 
attempting to improve outcomes of morbidity and mortality 
related to CAD. This emphasizes the importance of early screen-
ing and improved treatment strategies for occult CAD in as-
ymptomatic individuals.32) Moreover, CAD is a multifactorial 
disease that is influenced by numerous risk factors as well as so-
cioeconomic status. Therefore, it seems more clinically benefi-
cial to estimate the risk of CAD by simultaneously considering 
numerous factors associated with CAD rather than focusing 
on single factors alone. The Framingham heart study initially 
developed a risk algorithm to predict the development of CAD, 
and included major risk factors such as age, sex, systolic blood 
pressure, total cholesterol, high-density lipoprotein cholester-
ol, smoking behavior, DM status, and electric left ventricular 
hypertrophy.33) Since, the Framingham risk score (FRS) has 
continuously been developed34) and widely adopted for the 
prediction of the absolute risk of future cardiovascular events 
worldwide.35)
A potential drawback of the FRS is its development in a pre-
dominantly Caucasian middle-class study sample; hence, gen-
eralization of this algorithm to other diverse ethnic populations 
may be somewhat limited. Considering most individuals tend 
to have multiple sub-threshold risks, determining their true 
personal cardiovascular risk is often more difficult. In light of 
this, the FRS may not be suitable or practical for identifying di-
verse high cardiovascular risk populations.7)
Several studies have assessed the validity and utility of the 
FRS. Based on results of a multiple ethnic groups investiga-
tion, for white men and women as well as for black men and 
women, FRS performed reasonably well for prediction of car-
diovascular risk within 5 years of follow-up.8) On the other 
hand, FRS largely overestimated the risk among Native Amer-
ican women, Hispanic men, and Japanese Americans. A num-
ber of investigators also indicated that overestimation of car-
diovascular risk was reported when FRS was directly applied 
to other populations in Asia7)8) including Korea,13) as well as 
across Europe, in countries such as Germany,9) Spain,10) France,11) 
and Italy.12) Liu et al.7) assessed the predictive performance of 
the FRS in a large Chinese population. In that study, FRS over-
estimated the 10-year absolute CAD risk in both Chinese men 
and women with larger predicted differences compared with 
actual observed rates. For instance, among men in the 10th 
risk decile, the predicted rate of CAD mortality was 20% com-
pared with an observed rate of 3%. In another study consist-
ing of French men, the overall FRS estimated that the number 
of CAD events was twice as high when compared with the ac-
tual observed number of CAD events.11)
The results of previous studies displaying discrepancies be-
tween observed and predicted risk of CAD have significant 
implications for the primary prevention of CAD, as the over-
estimation of absolute risk could lead to inappropriate or inad-
equate treatments and excessive expenditures in individuals 
who have actually lower CAD risk than anticipated. Against 
this background, prior studies have undertaken large efforts to 
recalibrate the original FRS, in an effort to improve predictive 
ability.7)8)12) In a large cohort study comprising multiple ethnic 
groups residing in the US, the FRS fit well in other popula-
tions following recalibration, even after considering the differ-
ence in prevalent risk factors and underlying rates of develop-
ing CAD.8) Foremost, while the original FRS model appeared 
to overestimate actual observed CAD events, the recalibrated 
FRS model was in close agreement with the new model in this 
study. In addition, numerous efforts have been made to estab-
lish a novel risk prediction tool that is suitable for estimating 
cardiovascular risk, depending on specific race or ethnicity.9)13) 
For example, in Korea, Jee et al.13) developed a new CAD pre-
diction tool and demonstrated that the model provided accu-
rate and reliable prediction of cardiovascular risk specifically 
among Korean individuals.
Predictive Value of CAC Score
To date, there have been numerous risk prediction models, 
serum biomarkers, and imaging modalities for the purpose of 
screening CVD in asymptomatic individuals. Among them, 
CAC score is a specific surrogate marker of calcific atheroscle-
rosis in the coronary arteries and is frequently used to quantify 
coronary atherosclerotic plaque burden.36) The CAC score de-
termined by cardiac computed tomography (CT) has been well 
established as a robust imaging modality for early detection of 
CAD, enabling direct visualization of coronary atherosclerosis, 
particularly in asymptomatic individuals as compared to other 
cardiac risk factor-based paradigms.37)
A robust relationship has been found between CAC score 
and atherosclerotic burden as well as future cardiovascular 
events in asymptomatic populations. Indeed, increasing CAC 
score has been consistently associated with increased cardio-
vascular risk.38) In addition, others have found that the CAC 
score provides incremental benefit over and above convention-
al risk factors. Although the FRS has often proven to be a use-
ful risk algorithm, this prediction tool may misclassify a num-
ber of truly high-risk individuals who are likely to benefit from 
preventive treatment.39) To this end, previous studies have in-
dicated that the CAC score provides incremental benefit in ad-
dition to the FRS and additional advantage towards risk strat-
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ification when assessing cardiovascular risk. Greenland et al.40) 
reported that CAC score assessment combined with FRS in 
asymptomatic persons provides prognostic information superi-
or to either method alone. In the Multi-Ethnic Study of Athero-
sclerosis (MESA), Yeboah et al.41) compared the predictive 
utility of several novel risk markers for incident CVD and 
documented superior discrimination and reclassification based 
on the CAC score. Albeit, while CAC score is considered to 
improve risk classification as advocated by recent guidelines,14) 
the results from prior studies are largely derived from predom-
inantly Caucasian populations, with findings according to 
other racial or ethnic groups still lacking.29)
Racial and Ethnic Differences 
in Coronary Artery Calcification
Few recent studies have found some differences in the preva-
lence and severity of CAC score according to race and ethnici-
ty.15-18) In a sample of 1461 asymptomatic high-risk adults, Tang 
et al.17) demonstrated significant ethnic differences in the prev-
alence of coronary calcium. In that study, African Americans 
were found to have a significantly lower prevalence of coronary 
calcium as compared with Asian Americans or Caucasians. 
Budoff et al.16) reported that African Americans and Asians 
had a lower prevalence and severity of calcification compared 
with non-Hispanic Whites and Hispanics. These disparities 
persisted after adjusting for standard cardiac risk factors. In 
the MESA Study, there was a similar result of a substantially 
lower prevalence of coronary calcification among Hispanics and 
blacks versus whites and a slightly lower prevalence in Chinese 
versus whites.15) Also, in that study, even after controlling for 
risk factors, the prevalence of CAC score was lower in ethnic 
minorities. More recently, in a cross-sectional study comparing 
CAC score between US Caucasian men and Japanese men,42) 
the investigators found that Caucasian men aged between 45–
74 years had a higher burden of coronary artery atherosclerosis 
compared with Japanese men of the same age. In addition, this 
trend appeared to become more prominent with advancing 
age, even after adjusting for traditional risk factors.
Despite recent advances offering insight into the ethnic and 
racial disparities in CAC scores, the precise factors that actually 
modify CAC score on the background of race or ethnicity are 
not well defined. Several possible mechanisms have been con-
sidered. Notably, ethnic minorities tend to present with a high-
er number of conventional risk factors, comorbidities, and a 
lower access to health care treatment.29) Further still, other fac-
tors including behavioral, environmental, biochemical, and 
genetic predispositions, may modify the CAC score according 
to ethnicity or race. Though, clearly, additional studies are need-
ed to test this notion.
Reappraising the Value of CAC Score 
in Asian Populations
Prior studies have investigated the differences in the preva-
lence and severity of CAC score according to race and ethnici-
ty. However most of the extant CAC score literature has pre-
dominantly highlighted its relationship with adverse outcomes 
among Caucasian populations. Several previous studies have 
reported CAC score incremental to conventional risk factors in 
Korean adults.43-48) Table 1 summarizes the results of available 
studies that examined the prognostic value of CAC score among 
Table 1. The studies investigating value of CAC score in Asian population
Authors Settings Population (n) Follow-up duration (yr) Main findings
Park et al.43) Retrospective 
cohort
Korea (5182) 4.0 CAC score predicted adverse cardiac outcome alone, when assessed with other 
parameters, degree of stenosis performed better as a prognostic tool than  
CAC score
Kim et al.44) Cross-sectional Korea (7988) FRS underestimated cardiovascular risk in around 10% and by CAC score, 
9.4% was reclassified to the discordantly higher risk group. CAC score  
should be considered for more accurate risk stratification in subjects at  
low to moderate risk
Sung et al.45) Cross-sectional Korea (1653) Risk stratifications by CAC score and 10-year FRS showed a large discrepancy 
in around 9% of participants. CAC score is more useful predictor in adults  
older than 50 years and/or in metabolic syndrome patients
Itani et al.46) Prospective 
cohort
Japan (6120) 4.0 CAC was detected in 10 of 14 patients (71.4%) who died of cardiac disease, 
and in 31 of 64 patients (48.4%) who died of other diseases (p = 0.084).  
The relative risk of CAC for cardiac death was 2.66 (95% CI: 0.76–9.37)
Fujimoto et al.47) Retrospective 
cohort
Japan (2238) 1.8 High CAC score and non-culprit high-risk plaque on CCTA performed before 
revascularization are significant predictors of cardiac events after  
revascularization, with greatly discriminatory power
Yamamoto et al.48) Retrospective 
cohort
Japan (317) 6.0 HR for cardiac death in patients with a CAC score > 1000 was 2.98 (95% CI: 
1.15–9.40) compared with those with a CAC score 0 to 100. CAC score has  
a predictive value for CAD and long-term mortality from cardiac disease
CAC: coronary artery calcium, FRS: Framingham risk score, CCTA: coronary computed tomography angiography, CAD: coronary artery disease, HR: hazard 
ratio, CI: confidence interval
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study populations across Asia. Park et al.43) revealed that CAC 
score was an important predictor of poor cardiovascular out-
comes when evaluated alongside traditional biomarkers and 
risk factors; however, when the extent of coronary stenosis was 
added to the model, CAC score did not improve prognostic 
power. Another study comprising 7988 Korean participants at 
intermediate cardiovascular risk evaluated the differences among 
risk stratifications along with the National Cholesterol Educa-
tion Program-Adult Treatment Panel III (NCEP-ATP III) guide-
line and CAC score.44) In that study, the NCEP-ATP III guide-
lines underestimated cardiovascular risk in approximately 10% 
of enrolled individuals, whereas 9.4% were correctly reclassi-
fied to the higher risk group by including CAC score, thus em-
phasizing that CAC score should be considered for more accu-
rate risk classification. Nevertheless, while the effectiveness of 
CAC score has been universally verified in numerous popula-
tions, its utilization is often overlooked in clinical practice in 
Korea. Given these circumstances, further studies among Asian 
Table 2. Examination components of the KOICA registry
Examination components Description
Demographics
Sex, age, height, weight, BMI, weight circumflex, SBP, DBP, HR Measured and collected at the time of each visit to the healthcare centers 
Past disease history
HTN, CAD, hyperlipidemia, DM, CKD, and stroke Based on self-reported medical questionnaires about past 
history or current medication
Family disease history
HTN, CAD, DM, and stroke Based on self-reported medical questionnaires
Smoking status Based on self-reported medical questionnaires
Alcohol use Based on self-reported medical questionnaires
Lifestyle
Exercise status, time and frequency Based on self-reported medical questionnaires
Socioeconomics
Education and income Based on self-reported medical questionnaires
Laboratory tests
CBC
WBC, Hb, hematocrit, platelet Obtained at the time of each visit to the healthcare centers
Serum chemistry
HbA1c, glucose, BUN, creatinine, lipid profile (TC, TG, HDL, LDL), total 
protein, albumin, liver function test (total bilirubin, GGT, AST, ALT), thyroid 
function test T3, free T4, TSH), electrolytes (Na, K, Cl, tCO2, Ca, P), uric acid, 
high-sensitivity CRP
Obtained at the time of each visit to the healthcare centers
Urine analysis
Urine pH, protein, glucose Obtained at the time of each visit to the healthcare centers
Cardiovascular screening tests
CAC scanning
Agatston score, calcium volume and mass Acquired by using a greater than 16-slices multi-detector 
CT scanner
Each center used specific CT scanner types (the Philips 
Brilliance 256 iCT, Philips Brilliance 40 channel  
multi-detector CT, Siemens 16-slice Sensation, and  
GE 64-slices Lightspeed)
Arterial stiffness assessment baPWV was evaluated in two sites
CAVI was measured at one site using a VaSera VS-1000 
(Fukuda Denshi Co. Ltd., Tokyo, Japan)
Exercise treadmill test Performed using Bruce protocol (Quinton Q4500, 
Cardiac Science Corp., Bothell, WA, USA and 
Case8000, GE Healthcare, Wauwatosa, WI, USA)
Exercise capacity was recorded as METs
BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, HR: heart rate, HTN: hypertension, CAD: coronary artery disease, DM: 
diabetes mellitus, CKD: chronic kidney disease, CBC: complete blood count, WBC: white blood cell, Hb: hemoglobin, BUN: blood urea nitrogen, TC: total 
cholesterol, TG: triglyceride, HDL: high-density lipoprotein, LDL: low-density lipoprotein, GGT: gamma-glutamyl transpeptidase, AST: aspartate amino-
transferase, ALT: alanine transaminase, TSH: thyroid stimulating hormone, CAC: coronary artery calcium, Na: sodium, K: potassium, Cl: chloride, tCO2: total 
carbon dioxide, Ca: calcium, P: phosphorus, CRP: C-reactive protein, baPWV: brachial-ankle pulse wave velocity, CAVI: cardio-ankle vascular index, METs: 
metabolic equivalen, KOICA: Korea initiatives on coronary artery calcification, HbA1c: glycated hemoglobin
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individuals, especially Koreans, are warranted in order to reap-
praise the efficacy and predictive significance of the CAC score, 
which has been proven to be superior to other traditional risk 
prediction algorithms. Hence, the KOICA registry was designed 
to evaluate the usefulness and prognostic importance of CAC 
score for predicting all-cause mortality (ACM) in a large cohort 
of asymptomatic Korean adults.
KOICA Registry
Study design
The KOICA registry is a retrospective, single ethnicity mul-
ticenter observational study designed to investigate the effec-
tiveness and prognostic value of CAC score for primary preven-
tion of CVD in asymptomatic Korean adults. Overall, there 
were 3 sites involved in the KOICA registry. The study popu-
lation includes self-referred individuals who underwent self-
reported medical questionnaires to obtain personal clinical data 
and medical history with the purpose of a health check-up at a 
healthcare center in South Korea. A total of 48903 subjects 
were initially enrolled in the study between December 2002 
and July 2014. The appropriate institutional review board com-
mittees at each study site approved the study protocol, and all 
study participants provided written informed consent.
Study measures
Table 2 summarizes the examination components of the KO-
ICA registry. All data were obtained using a health check da-
tabase at the healthcare center of each site in South Korea. Base-
line demographic parameters were measured at the time of 
each visit to the health care centers and collected by self-report-
ed medical questionnaires. Each underlying disease including 
hypertension, CAD, hyperlipidemia, and DM was defined ac-
cording to participants’ self-reported medical history. Labora-
tory tests were obtained from a complete blood count, serum 
chemistry, and urinalysis that included numerous biochemical 
parameters. Other cardiovascular screening tests for risk assess-
ment included arterial stiffness assessment and exercise tread-
mill test. Though, it bears mentioning that not all demograph-
ic parameters or tests were performed in all patients, which 
will likely lead to some heterogeneity in forthcoming analytic 
sample sizes. 
CAC screening procedures
CAC score was acquired using a greater than 16 slice multi-
detector CT scanner. Specific CT scanner types used within 
each center included the Philips Brilliance 256 iCT (Philips 
Healthcare, Cleveland, OH, USA), Philips Brilliance 40 chan-
nel MDCT (Philips Healthcare, Cleveland, OH, USA), Siemens 
16-slice Sensation (Siemens, Forchheim, Germany), and GE 
64-slice Lightspeed (GE Healthcare, Milwaukee, WI, USA). 
All three centers performed standard prospective or retrospec-
tive methods.
Study endpoint
The mean follow-up duration was 4.8 years (interquartile 
range: 2.7–6.7 years). The primary endpoint in the KOICA 
registry is ACM, which was confirmed by querying the Min-
istry of Security and Public Administration records up until 
December 2014 for 2 centers, and up until September 2014 for 
the remaining center, allowing for 100% ascertainment of mor-
tality status. Over the course of the study period, a total of 415 
(0.9%) events were recorded in the KOICA registry. Accord-
ing to the Personal Information Protection Act, only data regard-
ing all-cause and not cause-specific mortality were available 
for analysis
Statistical methods and study objectives
Continuous variables are reported as mean ± standard devia-
tion, and categorical variables are reported using counts with 
proportions. For continuous parameters, Student’s t-test or 
Wilcoxon rank-sum test will be employed as appropriate for 
two-group comparisons, or one way ANOVA or Kruskal-Wal-
lis test for more than two-group comparisons, as appropriate. 
Comparison of categorical variables will be performed using 
Pearson’s chi-square test. The primary objective of the KOI-
CA registry is to determine the effectiveness of CAC score for 
predicting adverse outcomes in asymptomatic Korean adults, 
with ACM as the study endpoint. Cumulative ACM event rates 
over time according to CAC score categories will be estimated 
using the Kaplan Meier survival curve and compared using 
the log rank test. Multivariable Cox proportional hazards re-
gression models will be used to calculate the hazard ratios with 
95% confidence intervals (95% CIs) for risk of ACM according 
to CAC score categories. The added prognostic value of CAC 
score over and above established risk factors (e.g., the FRS) 
will be evaluated using the likelihood ratio χ2 test, the C-sta-
tistic, as well as the continuous net reclassification improve-
ment index. In secondary analyses, we intend to examine: 1) 
the usefulness of atherosclerotic burden as determined by CAC 
score for predicting ACM according to pre-specified sub-
groups; 2) the CAC score as a valid and robust cardiovascular 
tool among Koreans. Additional to the above mentioned sta-
tistical procedures, we will also study the diagnostic perfor-
mance of CAC score by determining sensitivity, specificity, as 
well as negative and positive predictive values in an effort to 
establish the CAC score as a useful screening tool among as-
ymptomatic Korean adults; and 3) we will analyze the dispar-
ity, if any, in the severity and outcome of CAC according to 
ethnic and socioeconomic background via the international 
cooperation institutions database. Using a binary logistic re-
gression approach reporting odds ratios with 95% CI, we will 
employ a propensity matching method that will permit match-
ing of patients from both ethnic cohorts according to available 
demographic characteristics, with the exception of the out-
come CAC score.
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Discussion
The KOICA registry will provide essential information for 
determining the effectiveness of CAC score for primary preven-
tion of CVD along with its role in determining clinical CVD in 
a large cohort of asymptomatic Korean adults. The KOICA 
registry will enable investigators to identify the characteristics, 
severity and determinants of CAC score for the purpose of de-
termining Asian-specific cut-off values for screening high-risk 
Korean adults. The analysis of the relationship between CAC 
score and traditional risk factors will also be performed. Based 
on prior findings primarily derived from Western populations, 
we anticipate that CAC score may provide incremental benefit 
over and above other risk assessment models for predicting ad-
verse outcomes. To examine the potential disparity according 
to race or ethnicity, cross-sectional comparison studies will be 
considered between the KOICA registry and other external 
study databases comprising different ethnicities in order to eval-
uate the prevalence and distribution of CAC score and/or events. 
Further, the long-term protective effects of a zero CAC score 
can be assessed given the latter beneficial effects are yet to be 
determined in a Korean population. Also, the KOICA registry 
will have the capability to evaluate possible interactions be-
tween CAC score and other cardiac risk factors that are avail-
able in this study.
Though we anticipate the KOICA registry will provide im-
portant and additional information to the extant CAC litera-
ture, our registry has some inherent limitations that should be 
emphasized. The present study is retrospective and observa-
tional in nature and only recorded a single measure of the 
CAC score, which will make it a challenge to interpret a long-
term causal relationship. Although the KOICA registry incor-
porates a substantial number of predictors and covariates, as is 
the case with most observational studies, we cannot discount 
the possibility of residual confounding due to unmeasured pa-
rameters. Our study participants were self-referred at routine 
health check-up programs, which may have inferred selection 
bias (i.e., healthy volunteers, or higher socio-economic status). 
Thus rendering our study sample not fully representative of 
the overall Korean population. Our study sample is predomi-
nantly male; hence caution should be taken when extrapolat-
ing our findings to women. Further still, despite the large sam-
ple size, the incidence of ACM is relatively small, as this registry 
was derived from a health check-up database, which limits the 
event rate that occurred during the follow-up period. In addi-
tion, the current study includes only self-reported information 
regarding certain participants’ demographics (i.e., medication 
use), which, in some cases, may potentially lead to a dimin-
ished risk prediction. Last, there is no information regarding 
cause-specific mortality in this registry. Though, prior reports 
have revealed that the assessment in the accuracy of death cer-
tificates has been mostly problematic, typically with an over-
estimation of cardiac death.49) To this end, the use of ACM as 
the primary endpoint provides an unbiased endpoint in the 
absence of cause-specific mortality.50)
Conclusion
Revaluating the prognostic utility of CAC score, which has 
been proven to be superior to other traditional risk prediction 
algorithms, is urgently needed, especially among non-Western 
populations. In light of this, the KOICA registry will provide 
some information regarding the effectiveness and prognostic 
value of CAC score for primary prevention of CAD, and may 
also help identify optimal criteria with regards to screening for 
cardiovascular risk among asymptomatic Asian (i.e., Korean) 
adults. Foremost, the anticipated findings from the KOICA 
registry may prove useful for eliminating unnecessary medical 
costs by providing appropriate individualized treatment strat-
egies. In time, it is expected that the KOICA registry will 
lend substantially towards understanding the important role 
CAC score might have for prognostication in asymptomatic 
Korean adults and how these finding may reflect differently 
when compared with other racial or ethnic groups.
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